My guess on the lack of data mining is that the patient population in the Panzem trials were just too small. I'm not sure what percentage of the patient population in the Panzem trials had RA but it's possible that the #'s would be statistically insignificant (although 100% response rate of even 2 patients would be significant to me!). Ken